Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
64 hedge funds and large institutions have $315M invested in Applied Therapeutics in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 7 closing their positions.
271% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 7
150% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 10
132% more capital invested
Capital invested by funds: $136M → $315M (+$179M)
42% more funds holding
Funds holding: 45 → 64 (+19)
14.77% more ownership
Funds ownership: 29.14% → 43.91% (+15%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.7M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$33.4M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$21.5M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$14M |
| 2 |
PWPCM
Perella Weinberg Partners Capital Management
New York
|
-$10.9M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$3.68M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.86M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.32M |
APLT Hedge Fund Activity: Q1 2020 in Review
64 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q1 2020, worth a combined $315M — up 132% from $136M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new APLT positions and 7 closed out — a net gain of 19 holders — while 25 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $36.7M. The largest seller was Emerald Mutual Fund Advisers Trust, cutting an estimated $14M.
- 64 institutional investors held Applied Therapeutics (APLT) as of Q1 2020, up from 45 in Q4 2019.
- Funds reported $315M of Applied Therapeutics stock for Q1 2020, up 132% quarter-over-quarter.
- 26 funds opened new Applied Therapeutics positions in Q1 2020 and 7 closed out, a net change of +19 holders.
- The largest Applied Therapeutics buyer in Q1 2020 was Fidelity Investments, an estimated $36.7M added.
- The largest Applied Therapeutics seller in Q1 2020 was Emerald Mutual Fund Advisers Trust, an estimated $14M sold.
Based on aggregated 13F filings for Q1 2020.